Skip to content

Caro Med, Inc.

United StatesFDA applicant, unverified

Devices
2

What Caro Med, Inc. makes

Caro Med, Inc. manufactures continuous glucose monitoring systems, including the GLUCOSE V and GLUCOSE 3 devices, designed for real-time blood glucose tracking in diabetic patients.

These devices are classified as Class II under FDA regulations and are authorised via the 510(k) pathway. The company is based in the United States.

AI-generated from registry data, 3 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

  • Glucose V Ref K910573

    Active Regimes: 510(k) Registry: 510(k) Class:II

  • Glucose 3 Ref K922035

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Caro Med, Inc. have in the registry?

The registry currently lists 2 devices for Caro Med, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Caro Med, Inc.'s devices?

Among its 2 most recently registered devices, Caro Med, Inc. has devices listed in FDA 510(k) (2 devices).

What risk classes do Caro Med, Inc.'s devices fall under?

Among its 2 most recently registered devices, the classes recorded for Caro Med, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Caro Med, Inc. in the registry?

The most recently registered devices listed for Caro Med, Inc. include GLUCOSE V and GLUCOSE 3.

Generated automatically from registry data and not verified by a human reviewer.